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INTRODUCTION
Agonist opioids bind to mu, kappa and delta receptors promoting analgesia by reduction of neuronal transmission (SCHULTZ & GROSS, 2001) . Studies on the effects of kappa agonists have been done and it has been noticed that U50-488H, considered as archetype of group, promotes analgesia without altering the locomotor activity of horses (KAMERLING et al., 1988 In the 1950s, Vital Brazil observed absence of inflammation and local analgesia after Crotalus durissus terrificus bites (SOUSA E SILVA et al., 1996) . In rats, crotalic venom causes prolonged analgesia in models of inflammatory (BRIGATTE et al., 2001) , neuropathic (GUTIERREZ et al., 2008) or oncologic pain (BRIGATTE et al., 2013) . The analgesic peptide in the crotalic venom was identified, characterized, synthesized and is currently called crotalphine (GIORGI et al., 1993) . It acts on kappa receptors present in supraspinal centers of the central nervous system (PICOLO et al., 1998; BRIGATTE et al., 2001) . Peripherally, crotalphine binds to kappa and delta receptors and also involves the NOGMPc L-arginine pathway and the ATP-sensitive K+ channels (PICOLO et al., 2000; PICOLO et al., 2003; PICOLO & CURY, 2004) .
Pre-clinical assays with crotalphine verified powerful and persistent analgesia in rodents without severe side effects (PICOLO et al., 2000; BRIGATTE et al., 2001; PICOLO & CURY, 2004; NUNES et al., 2007) . Besides pre-clinical studies, there is only one study that had already evaluated antinociception promoted by crotalphine and no analgesia was observed in horses submitted to thermal stimulation on intact skin (GUIRRO et al., 2013) .
The aim of this study was to evaluate the clinical, behavioral and antinociceptive effects promoted by a single injection of crotalphine in horses.
MATERIAL AND METHODS
Nine castrated male and nine non-pregnant female Arabian horses, between four and six years old and 377±27kg were selected after physical exam, hemogram and total protein measurement. Each group was composed of four males and four females. Some animals were used more than once, in different groups, respecting intervals of 14 days between repetitions.
Crotalphine is still in test and is not available for commercial sale so far. The dose of crotalphine (3.8ng kg -1 ) employed in this study was calculated by allometric extrapolation from the dose used in rats and was previously tested in a pilot study with six horses.
Phase I -Clinical and behavioural effects
The horses were positioned in a horse stock at 8am and received a jugular catheter. After 30min resting, at basal time (T B ), heart rate (bpm); respiratory rate (mpm); rectal temperature (°C); intestinal motility, in scores (0 -no motility; 1 -incomplete movement; 2 -hypomotility; 3 -normal motility; 4 -hypermotility); head ptosis, mensuring the height of the head before and after administration of the drug and, to avoid discrepancies among horses, the percentage of the change was calculated; palpebral and lip ptosis (0 -absence; 1 -presence); and ataxia, in scores, adapted from BRYANT et al. (1991) (0 -stability; 1 -reduction of stability with some lateral movement; 2 -more intense lateral movement, trend to inclination; 3 -pelvic support in the stock, members crossed, sudden and frequent flexion of carpal joints) were evaluated.
At T0, drugs were injected with regards to group: GC (5mL NaCl 0.9%), GCRO (3.8ngkg -1 crotalphine) or GK (160µkg -1 U50-488H). Final volume was adjusted to 5mL and injection was given within 30 seconds. Immediately, parameters were recorded and other evaluations were carried out in T30 (min), T60, T90, T2h (hours), T3h, T6h, T12h, T24h, T2d (days), T3d, T5d and T7d. Moreover, latency and percentage of animals that had urinated and defecated until T3h were evaluated.
Phase II -Antinociceptive effect on intact skinin the scapular or ischial regions A vertical line (5cm) with rectangles at 1, 3 and 5cm was drawn in the scapular and contra-lateral ischial regions (top of the line was the projection of the ischial tuberosity beneath the skin). The horses received a jugular catheter, had their tails bandaged and after 30min resting (T B ), the nociceptive threshold to mechanical stimuli was evaluated in the scapular (NTMSsca) and ischial (NTMSisc) regions using von Frey filaments to verify the mean of cutaneous sensitivity at 1, 3 and 5cm around the vertical central line. NTMS was determined by the major filament unable to provoke aversive response (average among values obtained at 1, 3 and 5cm). Twenty minutes later (T0), drugs were injected: GC (5mL NaCl 0.9%) or GCRO (3.8ngkg -1 crotalphine). Immediately, NTMSsca and NTMSisc were evaluated and new evaluations were carried out at T3h, T6h, T12h, T24h, T2d, T3d, T5d andT7d.
Phase III -Antinociceptive effect on incised skin in the scapular or ischial regions A vertical line (5cm) with rectangles at 1, 3 and 5cm was drawn in the scapular and contralateral ischial regions. The horses received a jugular catheter, had their tails bandaged and, in sequence, lidocaine 2% (5mL, SC) was administered along the vertical central line of the scapular and contra-lateral ischial region. Then, the skin was incised (5cm) on the line and immediately sutured.
After 30min resting (TB), NTMSsca and NTMSisc were evaluated as in Phase II. Twenty minutes later (T0), drugs were injected: GCRO
phenylbutazone), and NTMSsca and NTMSisc were evaluated again and repeatedly at T3h, T6h, T12h, T24h, T2d, T3d, T5d, and T7d. In this phase, there was not a GC group to respect animal welfare and the 3Rs principle.
Statistical analysis Heart and respiratory rate, rectal temperature, latency to urinate and defecate were analyzed by ANOVA followed by Tukey (P<0.05). Non-parametric variables were analyzed by Kruskal-Wallis (P<0,05). Regarding NTMS, Kruskal-Wallis was used to compare values along time and among groups; and Mann Whitney, to verify differences between regions and between intact and incised skin (P≤0.05).
RESULTS AND DISCUSSION
No animal of GC urinated until T3h, while 17% of GCRO and 50% of GK did. Latency in GC was greater than 180min; in GCRO and GK it was 168±13min and 126±24min, respectively. Crotalphine and U50-488H must have similar responses because both are kappa agonists and no changes in diuresis parameters were reported after use of U50-488H in horses (KAMERLING et al., 1989) .
Until three hours, 67% of the horses of GC, 83% of GCRO and 50% of GK defecated and latency was 70±35min, 82±25min and 34±29min, respectively. This similarity among groups proves that kappa opioids do not interfere in intestinal motility (BUENO & FIORAMONTI, 1988; ROGER et al., 1994) . Intestinal motility did not significantly change because kappa agonists do not change gastrointestinal motility (SMITH & CHANG. 1993) . ROGER et al. (1994) had already no changes in cecocolic motility after injection of U50-488H in ponies, suggesting that kappa agonist can be better than mu opioids to relieve visceral pain in equine colic without interferences in motility (KAMERLING et al., 1989; DUCHARME, 2003) . Crotalphine is a kappa agonist and thus the same effects caused by U50-488H in horses are expected. Perhaps, crotalphine may be an alternative to reducing pain in horses with intestinal discomfort, but this hypothesis is yet to be confirmed in future studies.
Heart rate, respiratory rate and rectal temperature (Table 1) did not change significantly and values of GCRO and GK were similar. Subtle changes were verified in rectal temperature, but values remained within physiological range. Importantly, environmental temperature was not controlled and varied from 21°C to 31°C according to official meteorological sources. Crotalphine and U50-488H Table 1 -Standard heart rate (HH), respiratory rate (RR) and rectal temperature (RT) (mean ± SE) observed in Arabian horses after intravenous injection of 5mL NaCl 0.9% (GC), 3.8ngkg -1 crotalphine (GCRO) or 160µgkg -1 U50-488H (GK).
-----------------------GC--------------------------------------------GCRO--------------------------------------------GK-----------------------HR (bpm) RR (mpm) RT (°C) HR (bpm) RR (mpm)
RT ( Head, palpebral and lip ptosis and ataxia were not observed in any group. KAMERLING et al. (1988) and KAMERLING et al. (1989) already reported absence of behavioral changes after administration of kappa agonists.
Regarding the antinociceptive effect caused by crotalphine (Table 2 ), in a general way, it was possible to observe that crotalphine was more efficient than other drugs, mainly on incised skin of the ischial region. In any given moment, NTNSsci was lesser than the value observed at T B in GCRO and, until T6h, the NTNSsci was greater than T B . Comparing NTMSsca and NTMSisc from intact and incised skin, values in the ischial region were always significantly higher. Effects caused by crotalphine were more relevant at ischial region and comparing intact versus injured skin it could be observed that in the intact skin the crotalphine does not increase pain threshold. Nociceptive stimuli are conducted by different sensitive fibers to the dorsal horn of the spinal medulla and opioids modulate the nociceptive response and cause antinociceptive effect (TRUONG et al., 2003) . As observed, crotalphine promoted more analgesia on inflamed tissue and this findingis supported by previous studies which revealed that expression and distribution of receptors in damaged tissue change the potency of opioids ( VAN LOON et al., 2013) ; there is also activation of peripheral opioid receptors depending on the stage of the inflammatory reaction and opioids do not always act the same way on intact tissue because they induce release of IL-10, which has anti-inflammatory effect (JOHNSTON et al., 2004; IWASZKIEWICZ, 2013) and increase plasmatic level of glucocorticoids by stimulation of the hypothalamicpituitary-adrenal axis (CHISARI et al., 1998) . Besides, crotalphine was more efficient in the ischial region because mu receptors are distributed along the spinal medulla in horses, while kappa and delta receptors are restricted to the lumbosacral and cervical segments, respectively (VALADÃO et al., 2002) . Crotalphine acts similarly to crotalic venom, hence, analgesic effect produced by them be similar. In this study, long-term analgesia was observed and, in the model of hyperalgesia induced by carrageenan in rats, a single injection of crotalic venom caused potent analgesia after stimulation of the pelvic limb (PICOLO et al., 1998; PICOLO & CURY, 2004) and anti-inflammatory effects for seven days. This suggests that crotalic venom has prolonged anti-inflammatory activity and that the analgesic effect is better when this drug is administered at the beginning of the inflammation (NUNES et al., 2007) as done in the present study.
Antinociceptive effect of crotalphine had two phases best observed in the incised ischial region. In the first phase (T0 to T6h), NTMSisc was higher than what was observed in intact skin; in the second (from T6h to T3d), NTMSisc was similar to T B . Long-term analgesia caused by crotalphine corroborates PICOLO et al. (1998) , who reported long analgesia after crotalic venom injection in rodents, reflecting action on the hypothalamic-pituitary-adrenalaxis (CHISARI et al., 1998) and reduction of hyperalgesia in the inflamed area through inhibition of central sensitization (STUBHAUG et al., 1997) .
CONCLUSION
Intravenous injection of a single dose of crotalphine (3.8ngkg -1 ) does not cause important clinical or behavioral changes and promotes antinociceptive effect on the incised ischial region for seven days in horses. Moreover, crotalphine does not evoke relevant antinociceptive effect on the scapular region or on theintact skin of horses.
